| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
USIM5
|
7.47 | 9.2B | 7.40 | 0.45 | 3.70 | 8.2% | 15.3% | 70 | 33 | 16.14 | +83.5% | 71 | 0.33 |
|
GOAU4
|
10.39 | 13.8B | 24.13 | 0.73 | 3.20 | 13.4% | 13.0% | 66 | 60 | 20.14 | +70.4% | 66 | 0.81 |
|
CMIN3
|
5.92 | 32.0B | 13.83 | 4.52 | 5.88 | 42.1% | 16.9% | 64 | 54 | 6.69 | +9.8% | 73 | 1.31 |
|
CSNA3
|
5.32 | 7.1B | — | 0.55 | 6.34 | 4.8% | 6.9% | 53 | 62 | 12.20 | +89.3% | 25 | 4.01 |
|
GGBR4
|
23.74 | 46.7B | 28.49 | 0.89 | 7.05 | 6.4% | 17.0% | 51 | 29 | 26.78 | +9.2% | 67 | 0.29 |
|
VALE3
|
77.85 | 331.3B | 100.00 | 8.72 | 38.99 | 17.3% | 18.1% | 32 | 26 | 19.46 | -56.2% | 67 | 0.58 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.